News

Transplantation at Duke in the Time of COVID-19

Transplantation remains the last hope for many patients with end-stage organ failure. However, the COVID-19 pandemic has resulted in a nationwide decrease in transplants and organ donation.

Duke Surgery Ranks Third Nationwide in NIH Funding

The Duke Department of Surgery now ranks third among surgery departments nationwide in National Institutes of Health (NIH) funding received in 2019 according to the newly released Blue Ridge rankings. Duke Surgery has continued to rank in the top five nationally over the past 30 years, demonstrating the department’s long-standing commitment to investigate the impact of disease on patient health. With a diverse portfolio, including 78.7% of funding from the NIH, Duke Surgery faculty and staff perform a wide variety of research to improve the human condition.

Duke Health Ranks 8th Nationally in Organ Transplant Volume

In 2019, the Duke heart, lung, liver, and kidney transplant programs experienced unprecedented volume growth: more than 20% for most programs. With 521 total transplants performed in 2019, Duke Health now ranks 8th among U.S. transplant programs.

Duke Transplant Center Funding Opportunity

The Duke Transplant Center (DTC) of the Duke University School of Medicine aims to promote cross-disciplinary clinical, translational, and basic research with the ultimate goal of optimizing transplant organ longevity and improving quality of life of transplant recipients. This is the inaugural annual call from the DTC for proposals for pilot and feasibility studies.